Studies on the Mechanism of Hypertriglyceridemia Induced by Oral Contraceptives
We have heard convincing evidence this morning of the alterations in plasma lipids induced by a broad range of oral contraceptive preparations. Because of the epidemiological association between atherosclerotic cardiovascular disease and hyperlipoproteinemia, hypertriglyceridemia as well as hypercholesterolemia (1), and the possibility that progestational agents may therefore limit the relative immunity from atherosclerosis enjoyed by premenopausal women, we have begun to explore the mechanism of the hypertriglyceridemia of oral contraceptive therapy. These studies, then, evaluate the altered balance between triglyceride (TG) input and removal which result in a raised plasma TG concentration in women given oral progestational agents.
KeywordsOral Contraceptive Lipoprotein Lipase Ethinyl Estradiol Oral Contra Oral Contraceptive Therapy
Unable to display preview. Download preview PDF.
- 2.Fabian, E., Stork, A., Kobilkova, J., and Sponarova, J.: The activity of the lipoprotein lipase and estrogens. Enzym. Biol. Clin. 8:45–455 (1967).Google Scholar
- 11.Riggs, D.S.: The Mathematical Approach to Physiological, Problems, Williams and Wilkins Co., Baltimore, 1963, Chapter 11, pp 272–298.Google Scholar
- 12.Robinson, D.S.: The clearing factor lipase and its action in the transport of fatty acids between the blood and the tissues. Adv. Lipid Res. 11: 133–182 (1963).Google Scholar
- 19.Spellacy, W.N., Carlson, K.L. and Schade, S.L.: Human growth hormone levels in normal subjects receiving an oral contraceptive. J. Amer. Med. Assoc. 2: 115–118 (1967).Google Scholar